EvAluation of Clinical Effectiveness Of RoLenium Administered With Elpenhaler in Chronic Obstructive Pulmonary Disease (COPD) patientS in Daily Clinical Practice, in Greece

CompletedOBSERVATIONAL
Enrollment

1,730

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

COPD Pharmacologic Substance

COPD patients treated by Fluticasone / Salmetrol via Elpenhaler device

Trial Locations (2)

Unknown

University Hospital of Crete, Heraklion

University Hospital of Herakleion, Heraklion

Sponsors
All Listed Sponsors
lead

Elpen Pharmaceutical Co. Inc.

INDUSTRY